EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prophylactic proton pump inhibitor use and all-cause mortality in adult sepsis patients: a retrospective analysis based on the MIMIC-IV database

Prophylaktische Anwendung von Protonenpumpeninhibitoren und Gesamtmortalität bei erwachsenen Sepsis-Patient:innen: retrospektive Analyse auf Basis der MIMIC-IV-Datenbank

Chendong Ma, Lixin Zhang, Min Wang, Feng Zhang, Lipeng Zhang

Frontiers in Pharmacology · 19.06.2025 · 16

DOI: 10.3389/fphar.2025.1545533 ↗

Auf einen Blick

Bei 18.198 Sepsis-Patient:innen war prophylaktische PPI-Anwendung mit höherer 90-Tage-Gesamtmortalität assoziiert. 28- und 90-Tage-Modelle zeigten eine bessere Vorhersage als CCI und SOFA.

Fragestellung

Ist prophylaktische PPI-Gabe bei erwachsenen Sepsis-Patient:innen mit Überleben, Verweildauer und Nebenereignissen assoziiert?

Methode

Retrospektive Kohortenstudie mit Sepsis-3.0-Patient:innen aus der MIMIC-IV-Datenbank; Cox-Regression, ROC-Kurven und Kaplan-Meier-Analysen.

Ergebnisse

18.198 Sepsis-Patient:innen. Prophylaktische PPI-Anwendung war mit erhöhter 90-Tage-Gesamtmortalität nach ICU-Aufnahme assoziiert (P < 0,001). AUC: 0,74 (95 %-KI 0,73–0,75) für 28 Tage; 0,73 (95 %-KI 0,72–0,74) für 90 Tage.

Schlussfolgerung der Autor:innen

Prophylaktische PPI-Anwendung verbesserte das 28- oder 90-Tage-Überleben bei erwachsenen Sepsis-Patient:innen nicht. Sie war mit verkürzter ICU-Verweildauer, aber nicht mit kürzerem Krankenhausaufenthalt verbunden.

Kernaussagen

  • Höhere 90-Tage-Gesamtmortalität unter prophylaktischer PPI-Anwendung
  • ICU-Verweildauer um etwa 1 Tag reduziert
  • Assoziation mit Hypoalbuminämie und opportunistischen Infektionen

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.06.2025. Verfasst von Chendong Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Inner Mongolia Medical University Affiliated Hospital, Hohhot, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Major Project of Inner Mongolia Autonomous Region of China.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis poses a significant threat to human health, and extensive research has examined the relationship between proton pump inhibitors (PPI) and adverse outcomes in patients with sepsis. However, a consensus on this issue remains elusive. Therefore, this study aims to develop a prognostic model to assess the effectiveness of prophylactic PPI administration in patients with sepsis.

Methods

A retrospective cohort study was conducted using the open-access Medical Information Mart for Intensive Care (MIMIC-IV) database. Patients diagnosed with sepsis according to the Sepsis-3.0 criteria were selected for inclusion. The primary outcome of interest was all-cause mortality occurring between 28 and 90 days following prophylactic PPI use. Secondary outcomes included in-hospital and intensive care unit (ICU) mortality, duration of hospital and ICU stays, and the incidence of adverse events. Stepwise Cox proportional hazards regression analysis was performed, and multivariate Cox regression models were developed and evaluated using receiver operating characteristic (ROC) curves. Additionally, Kaplan–Meier curves were utilized to compare patient survival at 28 and 90 days.

Results

This study included 18,198 sepsis patients. The results demonstrated that prophylactic PPI use was significantly associated with increased 90-day all-cause mortality following ICU admission ( P < 0.001). Prediction models incorporating 28-day (training AUC 0.74; 95% CI 0.73–0.75) and 90-day (training AUC 0.73; 95% CI 0.72–0.74) outcomes exhibited superior accuracy compared to conventional CCI and SOFA scores. Notably, prophylactic PPI use reduced ICU stay by approximately 1 day in sepsis patients but did not reduce overall hospitalization. Additionally, PPI administration was linked to adverse events including hypoalbuminemia and opportunistic infections.

Conclusion

Prophylactic PPI use failed to improve 28-day or 90-day survival rates in adult sepsis patients. Although PPI use was associated with reduced ICU length of stay, it did not shorten total hospital stay duration. Additionally, PPI administration was linked to clinically significant adverse reactions.

Schlagwörter

Stichwörter der Autor:innen

MIMIC-IV databasepredictive modelprognosisproton pump inhibitorsrisk factorssepsis

Autor:innen und Institutionen

  • Department of Intensive Care Unit, Inner Mongolia Medical University Affiliated Hospital, Hohhot, China.
  • Department of Emergency, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Förderung

  • Science and Technology Major Project of Inner Mongolia Autonomous Region of China

Zitieren

APA

Ma, C., Zhang, L., Wang, M., Zhang, F., & Zhang, L. (2025). Prophylactic proton pump inhibitor use and all-cause mortality in adult sepsis patients: a retrospective analysis based on the MIMIC-IV database. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1545533

Vancouver

Ma C, Zhang L, Wang M, Zhang F, Zhang L. Prophylactic proton pump inhibitor use and all-cause mortality in adult sepsis patients: a retrospective analysis based on the MIMIC-IV database. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1545533

BibTeX
@article{Ma2025,
  author = {Ma, Chendong and Zhang, Lixin and Wang, Min and Zhang, Feng and Zhang, Lipeng},
  title = {Prophylactic proton pump inhibitor use and all-cause mortality in adult sepsis patients: a retrospective analysis based on the MIMIC-IV database},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1545533}
}
Kostenlos starten →